Overall length 355 mm, 14.0 inches.
Fluoroperm 151 lens meets special needs of certain patients who need exceptional oxygen permeability for specific corneal condition or lifestyle requirements.
Magniclear is the first presbyopic lens to combine the clear distance optics of a spherical lens, the intermediate visual performance of a multifocal and the predictably crisp, near power of a bifoca
... the Polycon II lens design with the exceptional p...thin lens that offers predictable fitting, crisp v...urability and superior oxygen delivery. Combined w...r service and expedited delivery, Artcon is the pe...
Medicine Products:(Date:11/21/2008)...s., Nov. 21 Cardiosolutions, Inc.,...ed the appointment of Dr. Lars,Svensson, M.D., Ph... Svensson,is currently the Director of the Center...ndrome and Connective Tissue Disorder Clinic in th...ry at Cleveland Clinic. , Cardiosolutions I...
(Date:11/21/2008)...v. 21 Draeger Safety, Inc., locate...a world leading safety products,provider, is coun...tions from,Sperian Respiratory Protection USA (fo... on the popular Draeger PSS7000 SCBA (Self-Contain... Draeger has a strong respect for intellectua...
(Date:11/21/2008)... Yankee Equity Solution (YES) has launc...Fund”, a private equity vehicle to help Mass... and profits to expand their commercialization eff...d will provide growth capital to medtech companies...rofitable (minimum $2 million EBITDA), and have th...
(Date:11/21/2008)... collaboration of Baxa Corporation, ClinicalIQ LLC...erstanding of, and compliance to, USP < 797 >...D, Colo., Nov. 21 Baxa Corporation...LC and Pharmacy OneSource, Inc. to convey a comple...nited States Pharmacopeia (USP) < 797 > regu...
Breaking Medicine News(10 mins):Health News:Cardiosolutions Names Dr. Lars Svensson Chief Surgical Officer 2Health News:Draeger Counters What It Believes Are Unsubstantiated Allegations of Patent Infringement by Sperian 2Health News: Yankee Equity Solution ("YES") Launches $50 Million Fund for Mass.-Based Medtech Companies 2Health News:Baxa Corporation Announces Co-Marketing Agreement With Industry Leaders Pharmacy OneSource, Inc and ClinicalIQ LLC 2Health News:Baxa Corporation Announces Co-Marketing Agreement With Industry Leaders Pharmacy OneSource, Inc and ClinicalIQ LLC 3Health News:Baxa Corporation Announces Co-Marketing Agreement With Industry Leaders Pharmacy OneSource, Inc and ClinicalIQ LLC 4(Date:11/20/2008)...SNewswire/ -- The following is being released by C...WHAT: World AIDS Day Audio Media Conference , ... 11:00 a.m. EST , Call-in number: 1-800-949-8...dytalk.com/r/1xe41i2yre8rs , , WHY: With... newly put on treatment worldwide, advocates are c...
(Date:11/20/2008)...r 20 Arpida (SWX:,ARPN)...isory Committee of the,U.S. Food and Drug Adminis...val of intravenous iclaprim, an antibiotic current...ith complicated skin and skin structure infections...resistant Staphylococcus,aureus (MRSA). , ...
(Date:11/20/2008)...wire/ -- Radius Health ("Radius") announced today ...s second institutional financing round, increasing...e total amount raised since the company,s inceptio...vestors participated in the financing, led by MPM ...l, The Wellcome Trust, HealthCare Ventures, Oxford...
(Date:11/19/2008)...e/ -- Posit Science Corporation,researcher, Dan T...science,Annual Conference in Washington, DC this ...it Baby Boomers. The computerized brain plasticit...exercises that target auditory and,language syste...ed,improvements in cognition by improving speed a...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Elbit Medical Imaging Ltd Announces Definitive Agreements for a Large Scale Luxury Mixed Use Project in Bangalore India 1401 1Elbit Medical Imaging Ltd Announces Definitive Agreements for a Large Scale Luxury Mixed Use Project in Bangalore India 1401 2Elbit Medical Imaging Ltd Announces Definitive Agreements for a Large Scale Luxury Mixed Use Project in Bangalore India 1401 3Elbit Medical Imaging Ltd Announces Definitive Agreements for a Large Scale Luxury Mixed Use Project in Bangalore India 1401 4Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs Angiographic Guidance of Stent Deployment in Patients with Multivessel 587 1Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs Angiographic Guidance of Stent Deployment in Patients with Multivessel 587 2A longer living healthier mouse that could hold clues to human aging 4239 1A longer living healthier mouse that could hold clues to human aging 4239 2Elsevier journals participate widely in global theme issue on poverty and human development 4235 1Elsevier journals participate widely in global theme issue on poverty and human development 4235 2... Three NCI-Sponsored Clinical Trials , SOUTH SAN F...rated (Nasdaq: CYTK) announced results from the an...sib administered as,monotherapy, one in patients w...lanoma, and one in patients with hormone-refractor...cule inhibitor of,kinesin spindle protein (KSP), a...
...-A cervical cancer vaccine has shown 90%,efficacy ... lesions,associated with the human papillomavirus ...ors of an Article published early Online,and in th...18 account for 70% or more,cases of cervical cance...types which can contribute to cervical cancer. , P...
Other Medicine Technology:Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 2Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 3Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 4Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 5Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 6Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 7Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 8Vaccine Can Prevent Cervical Cancer and Precancerous Lesions 2